Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Morgan Stanley $2 billion subordinated notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley $5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Ferguson $1 billion senior notes offering
We advised Ferguson on its Rule 144A / Regulation S notes offering
Natus Medical $1.2 billion acquisition by ArchiMed
We are advising Natus Medical on the transaction
Xponential Fitness $103.5 million secondary offering
The shares are listed on the New York Stock Exchange
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction
Equinix $1.2 billion green bonds offering
We advised Equinix on the investment-grade debt offering
Grupo Aval spinoff of BAC Holding International
We advised Grupo Aval on the unregistered spinoff of a 75% equity stake in its indirect subsidiary
HP $3.3 billion acquisition of Poly
We are advising HP on the transaction
Banco Santander $2.75 billion senior preferred and non-preferred notes offering
We advised Banco Santander on its offering of fixed-rate and fixed-to-fixed-rate notes